Amaral T - Search Results

1

Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).

Forschner A, Eichner F, Amaral T, Keim U, Garbe C, Eigentler TK. Forschner A, et al. Among authors: amaral t. J Cancer Res Clin Oncol. 2017 Mar;143(3):533-540. doi: 10.1007/s00432-016-2309-y. Epub 2016 Nov 22. J Cancer Res Clin Oncol. 2017. PMID: 27878363

2

The safety and efficacy of cobimetinib for the treatment of BRAF V600E or V600K melanoma.

Amaral T, Nouri N, Garbe C. Amaral T, et al. Expert Rev Anticancer Ther. 2016 Jul;16(7):705-15. doi: 10.1080/14737140.2016.1192469. Epub 2016 Jun 10. Expert Rev Anticancer Ther. 2016. PMID: 27219630 Review.

3

Acquired resistance mechanisms to immunotherapy.

Amaral T, Garbe C. Amaral T, et al. Ann Transl Med. 2016 Dec;4(24):547. doi: 10.21037/atm.2016.12.21. Ann Transl Med. 2016. PMID: 28149908 Free PMC article. No abstract available.

4

MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition.

Amaral T, Sinnberg T, Meier F, Krepler C, Levesque M, Niessner H, Garbe C. Amaral T, et al. Eur J Cancer. 2017 Mar;73:93-101. doi: 10.1016/j.ejca.2016.12.012. Epub 2017 Feb 3. Eur J Cancer. 2017. PMID: 28162869 Review.

5

The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition.

Amaral T, Sinnberg T, Meier F, Krepler C, Levesque M, Niessner H, Garbe C. Amaral T, et al. Eur J Cancer. 2017 Mar;73:85-92. doi: 10.1016/j.ejca.2016.12.010. Epub 2017 Feb 3. Eur J Cancer. 2017. PMID: 28169047 Review.

6

Non-melanoma skin cancer: new and future synthetic drug treatments.

Amaral T, Garbe C. Amaral T, et al. Expert Opin Pharmacother. 2017 May;18(7):689-699. doi: 10.1080/14656566.2017.1316372. Epub 2017 Apr 17. Expert Opin Pharmacother. 2017. PMID: 28414587 Review.

7

Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins.

Spänkuch I, Gassenmaier M, Tampouri I, Noor S, Forschner A, Garbe C, Amaral T. Spänkuch I, et al. Among authors: amaral t. Eur J Cancer. 2017 Aug;81:203-205. doi: 10.1016/j.ejca.2017.05.018. Epub 2017 Jun 20. Eur J Cancer. 2017. PMID: 28641200 No abstract available.

8

Reply to 'Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma'.

Amaral T, Garbe C. Amaral T, et al. Expert Opin Pharmacother. 2017 Oct;18(14):1537. doi: 10.1080/14656566.2017.1367596. Epub 2017 Aug 18. Expert Opin Pharmacother. 2017. PMID: 28812387 No abstract available.

9

Immunotherapy in managing metastatic melanoma: which treatment when?

Amaral T, Meraz-Torres F, Garbe C. Amaral T, et al. Expert Opin Biol Ther. 2017 Dec;17(12):1523-1538. doi: 10.1080/14712598.2017.1378640. Epub 2017 Sep 17. Expert Opin Biol Ther. 2017. PMID: 28891339 Review.

10

Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Amaral T, Leiter U, Garbe C. Amaral T, et al. Rev Endocr Metab Disord. 2017 Dec;18(4):517-532. doi: 10.1007/s11154-017-9433-0. Rev Endocr Metab Disord. 2017. PMID: 28916903 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters